GCMS-based metabolomic study in mice with colitis induced by dextran sulfate sodium

Inflammatory Bowel Diseases

Volumn 17, Issue 11, 2011, Pages 2261-2274

  Shiomi, Yuuki ^a   Nishiumi, Shin ^a   Ooi, Makoto ^a   Hatano, Naoya ^a   Shinohara, Masakazu ^a   Yoshie, Tomoo ^a   Kondo, Yasuyuki ^a   Furumatsu, Keisuke ^a   Shiomi, Hideyuki ^a   Kutsumi, Hiromu ^a   Azuma, Takeshi ^a   Yoshida, Masaru ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

colitis; GC MS; metabolomics; PLS DA

Indexed keywords

AMINO ACID; DEXTRAN SULFATE; GLUTAMIC ACID; GLUTAMINE; INDOLEACETIC ACID; SUCCINIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CITRIC ACID CYCLE; COLITIS; COLON; CONTROLLED STUDY; FEMALE; GAS CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; MASS SPECTROMETRY; METABOLOMICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SERUM;

ADULT; ANIMALS; BIOLOGICAL MARKERS; BODY WEIGHT; CASE-CONTROL STUDIES; COLITIS; COLON; DEXTRAN SULFATE; DISEASE MODELS, ANIMAL; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; GLUTAMINE; HUMANS; MALE; METABOLOMICS; MICE; MICE, INBRED C57BL; MIDDLE AGED;

EID: 79959895766     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.21616     Document Type: Article

References (40)

1. Baumgart DC, Sandborn WJ,. Inflammatory bowel disease: clinical aspects and established and evolving therapies. Lancet. 2007; 369: 1641-1657. (Pubitemid 46722637)
2. Hugot JP, Chamaillard M, Zouali H, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature. 2001; 411: 599-603. (Pubitemid 32531408)
3. Rioux JD, Daly MJ, Silverberg MS, et al. Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease. Nat Genet. 2001; 29: 223-228. (Pubitemid 32952663)
4. Stoll M, Corneliussen B, Costello CM, et al. Genetic variation in DLG5 is associated with inflammatory bowel disease. Nat Genet. 2004; 36: 476-480. (Pubitemid 38620031)
5. Barrett JC, Hansoul S, Nicolae DL, et al. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat Genet. 2008; 40: 955-962.
6. Kanmura S, Uto H, Numata M, et al. Human neutrophil peptides 1-3 are useful biomarkers in patients with active ulcerative colitis. Inflamm Bowel Dis. 2009; 15: 909-917.
7. Shkoda A, Werner T, Daniel H, et al. Differential protein expression profile in the intestinal epithelium from patients with inflammatory bowel disease. J Proteome Res. 2007; 6: 1114-1125. (Pubitemid 46480475)
8. Alex P, Gucek M, Li X,. Applications of proteomics in the study of inflammatory bowel diseases: current status and future directions with available technologies. Inflamm Bowel Dis. 2009; 15: 616-629.
9. Oliver SG, Winson MK, Kell DB, et al. Systematic functional analysis of the yeast genome. Trends Biotechnol. 1998; 16: 373-378. (Pubitemid 28410425)
10. Romero R, Espinoza J, Gotsch F, et al. The use of high-dimensional biology (genomics, transcriptomics, proteomics, and metabolomics) to understand the preterm parturition syndrome. BJOG. 2006; 113 (suppl 3): 118-135. (Pubitemid 44934682)
11. Chan EC, Koh PK, Mal M, et al. Metabolic profiling of human colorectal cancer using high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy and gas chromatography mass spectrometry (GC/MS). J Proteome Res. 2009; 8: 352-361.
12. Nambiar PR, Gupta RR, Misra V,. An "Omics" based survey of human colon cancer. Mutat Res. 2010; 693: 3-18.
13. Rochfort S,. Metabolomics reviewed: a new "omics" platform technology for systems biology and implications for natural products research. J Nat Prod. 2005; 68: 1813-1820. (Pubitemid 43082664)
14. Okayasu I, Hatakeyama S, Yamada M, et al. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology. 1990; 98: 694-702. (Pubitemid 20069706)
15. Cooper HS, Murthy SN, Shah RS, et al. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest. 1993; 69: 238-249.
16. Hudert CA, Weylandt KH, Lu Y, et al. Transgenic mice rich in endogenous omega-3 fatty acids are protected from colitis. Proc Natl Acad Sci U S A. 2006; 103: 11276-11281. (Pubitemid 44156509)
17. Ishida T, Yoshida M, Arita M, et al. Resolvin E1, an endogenous lipid mediator derived from eicosapentaenoic acid, prevents dextran sulfate sodium-induced colitis. Inflamm Bowel Dis. 2010; 16: 87-95.
18. Nishiumi S, Shinohara M, Ikeda A, et al. Serum metabolomics as a novel diagnostic approach for pancreatic cancer. Metabolomics. 2010; 6: 518-528.
19. Sutherland LR, Martin F, Greer S, et al. 5-Aminosalicylic acid enema in the treatment of distal ulcerative colitis, proctosigmoiditis, and proctitis. Gastroenterology. 1987; 92: 1894-1898. (Pubitemid 17072238)
20. Werner T, Shkoda A, Haller D,. Intestinal epithelial cell proteome in IL-10 deficient mice and IL-10 receptor reconstituted epithelial cells: impact on chronic inflammation. J Proteome Res. 2007; 6: 3691-3704. (Pubitemid 47522758)
21. Newsholme P,. Why is L-glutamine metabolism important to cells of the immune system in health, postinjury, surgery or infection? J Nutr. 2001; 131: 2515S-2522S; discussion 2523S- 2514S.
22. Brand K, Leibold W, Luppa P, et al. Metabolic alterations associated with proliferation of mitogen-activated lymphocytes and of lymphoblastoid cell lines: evaluation of glucose and glutamine metabolism. Immunobiology. 1986; 173: 23-34. (Pubitemid 16003268)
23. Windmueller HG,. Glutamine utilization by the small intestine. Adv Enzymol Relat Areas Mol Biol. 1982; 53: 201-237.
24. Martin FP, Rezzi S, Philippe D, et al. Metabolic assessment of gradual development of moderate experimental colitis in IL-10 deficient mice. J Proteome Res. 2009; 8: 2376-2387.
25. Ariake K, Ohkusa T, Sakurazawa T, et al. Roles of mucosal bacteria and succinic acid in colitis caused by dextran sulfate sodium in mice. J Med Dent Sci. 2000; 47: 233-241.
26. Fukui S, Shimoyama T, Tamura K, et al. Mucosal blood flow and generation of superoxide in rat experimental colitis induced by succinic acid. J Gastroenterol. 1997; 32: 464-471. (Pubitemid 27367975)
27. Chung KT, Anderson GM, Fulk GE,. Formation of indoleacetic acid by intestinal anaerobes. J Bacteriol. 1975; 124: 573-575.
28. Sartor RB,. Microbial influences in inflammatory bowel diseases. Gastroenterology. 2008; 134: 577-594. (Pubitemid 351173057)
29. Onderdonk AB, Hermos JA, Bartlett JG,. The role of the intestinal microflora in experimental colitis. Am J Clin Nutr. 1977; 30: 1819-1825. (Pubitemid 8212710)
30. Ardawi MS, Newsholme EA,. Fuel utilization in colonocytes of the rat. Biochem J. 1985; 231: 713-719. (Pubitemid 16194568)
31. Newsholme P, Lima MM, Procopio J, et al. Glutamine and glutamate as vital metabolites. Braz J Med Biol Res. 2003; 36: 153-163. (Pubitemid 36285058)
32. Fujita T, Sakurai K,. Efficacy of glutamine-enriched enteral nutrition in an experimental model of mucosal ulcerative colitis. Br J Surg. 1995; 82: 749-751.
33. Fox AD, Kripke SA, De Paula J, et al. Effect of a glutamine-supplemented enteral diet on methotrexate-induced enterocolitis. JPEN J Parenter Enteral Nutr. 1988; 12: 325-331.
34. Ameho CK, Adjei AA, Harrison EK, et al. Prophylactic effect of dietary glutamine supplementation on interleukin 8 and tumour necrosis factor alpha production in trinitrobenzene sulphonic acid induced colitis. Gut. 1997; 41: 487-493. (Pubitemid 27448780)
35. Neilly PJ, Gardiner KR, Kirk SJ, et al. Topical glutamine therapy in experimental inflammatory bowel disease. Clin Nutr. 1995; 14: 283-287.
36. Erbil Y, Berber E, Ozarmagan S, et al. The effects of sodium deoxycholate, lactulose and glutamine on bacterial translocation in common bile duct ligated rats. Hepatogastroenterology. 1999; 46: 2791-2795. (Pubitemid 29525278)
37. Boelens PG, Nijveldt RJ, Houdijk AP, et al. Glutamine alimentation in catabolic state. J Nutr. 2001; 131: 2569S-2577S; discussion 2590S. (Pubitemid 32847011)
38. Calder PC, Yaqoob P,. Glutamine and the immune system. Amino Acids. 1999; 17: 227-241. (Pubitemid 30113756)
39. Finnie IA, Taylor BA, Rhodes JM,. Ileal and colonic epithelial metabolism in quiescent ulcerative colitis: increased glutamine metabolism in distal colon but no defect in butyrate metabolism. Gut. 1993; 34: 1552-1558. (Pubitemid 23341847)
40. Bjerrum JT, Nielsen OH, Hao F, et al. Metabonomics in ulcerative colitis: diagnostics, biomarker identification, and insight into the pathophysiology. J Proteome Res. 2010; 9: 954-962.